These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1573980)

  • 21. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.
    Carris NW; Spinelli A; Pierini D; Taylor JR; Anderson KV; Sando K; Powell J; Rosenberg EI; Zumberg MS; Smith SM; Gums JG; Dietrich E
    Cardiovasc Ther; 2015 Jun; 33(3):98-103. PubMed ID: 25786578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting.
    Wittkowsky AK; Nutescu EA; Blackburn J; Mullins J; Hardman J; Mitchell J; Vats V
    Chest; 2006 Nov; 130(5):1385-9. PubMed ID: 17099014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of factors associated with stability of anticoagulation therapy.
    Rospond RM; Quandt CM; Clark GM; Bussey HI
    Pharmacotherapy; 1989; 9(4):207-13. PubMed ID: 2771806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
    Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
    Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for intracranial hemorrhage in outpatients taking warfarin.
    Hylek EM; Singer DE
    Ann Intern Med; 1994 Jun; 120(11):897-902. PubMed ID: 8172435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
    Nutescu EA; Bathija S; Sharp LK; Gerber BS; Schumock GT; Fitzgibbon ML
    Pharmacotherapy; 2011 Dec; 31(12):1161-74. PubMed ID: 22122179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic.
    Hamby L; Weeks WB; Malikowski C
    Eff Clin Pract; 2000; 3(4):179-84. PubMed ID: 11183433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology.
    Weingart SN; Cleary A; Scullion B; Morway L; Phantumvanit V; Stuver SO; Shulman LN; Connors JM
    J Oncol Pharm Pract; 2013 Sep; 19(3):237-45. PubMed ID: 23175451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
    Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
    J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective costing of warfarin.
    Walsh C; Murphy A; Kirby A; Vaughan C
    Ir Med J; 2014 May; 107(5):133-5. PubMed ID: 24908854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy.
    Albrecht R
    Manag Care Q; 2006; 14(1):13-6. PubMed ID: 17590971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?
    Lo A; Ryder K; Shorr RI
    J Am Geriatr Soc; 2005 Jul; 53(7):1162-7. PubMed ID: 16108934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient time requirements for anticoagulation therapy with warfarin.
    Jonas DE; Bryant Shilliday B; Laundon WR; Pignone M
    Med Decis Making; 2010; 30(2):206-16. PubMed ID: 19773584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden.
    Andersson S; Björholt I; Nilsson GH; Krakau I
    BMC Fam Pract; 2006 Nov; 7():67. PubMed ID: 17096858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.
    White RH; McCurdy SA; von Marensdorff H; Woodruff DE; Leftgoff L
    Ann Intern Med; 1989 Nov; 111(9):730-7. PubMed ID: 2802431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A flexible loading dose schedule for warfarin therapy.
    Fergusson RJ; Eade OE; Logie AW; Gaddie J
    Scott Med J; 1987 Dec; 32(6):169-71. PubMed ID: 3329767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
    Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.